STOCK TITAN

[8-K] Synopsys Inc Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Synopsys, Inc. (SNPS) filed an 8-K to disclose that the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) has rescinded the export restrictions that were imposed on certain Synopsys products sold into China on May 29, 2025. The rescission is effective immediately as of July 2, 2025.

The company states it is "working to restore access" for Chinese customers to the previously restricted products and is still evaluating how the temporary restrictions may affect its business, operating results, and overall financial condition. No quantitative impact or guidance revisions were provided in the filing. Management reminds investors that forward-looking statements are subject to risks and uncertainties disclosed in prior SEC reports.

While the 8-K contains no earnings data, the lifting of restrictions removes a potential headwind to Synopsys’ sales in a strategically important market. The filing does not mention any conditions, penalties, or ongoing limitations attached to the BIS decision. The company has not updated its outlook and expressly disclaims any obligation to do so after July 2, 2025.

Synopsys, Inc. (SNPS) ha presentato un modulo 8-K per comunicare che il Bureau of Industry and Security (BIS) del Dipartimento del Commercio degli Stati Uniti ha revocato le restrizioni all'esportazione imposte il 29 maggio 2025 su alcuni prodotti Synopsys venduti in Cina. La revoca è entrata in vigore immediatamente dal 2 luglio 2025.

L'azienda dichiara di essere "al lavoro per ristabilire l'accesso" ai prodotti precedentemente soggetti a restrizioni per i clienti cinesi e sta ancora valutando l'impatto che tali limitazioni temporanee potrebbero avere sul proprio business, sui risultati operativi e sulla situazione finanziaria complessiva. Nel documento non sono stati forniti dati quantitativi né revisioni delle previsioni. La direzione ricorda agli investitori che le dichiarazioni previsionali sono soggette a rischi e incertezze già indicati nei precedenti rapporti SEC.

Pur non contenendo dati sugli utili, la rimozione delle restrizioni elimina un potenziale ostacolo alle vendite di Synopsys in un mercato strategicamente importante. Nel documento non si menzionano condizioni, sanzioni o limitazioni in corso legate alla decisione del BIS. L'azienda non ha aggiornato le proprie previsioni e declina espressamente qualsiasi obbligo di farlo dopo il 2 luglio 2025.

Synopsys, Inc. (SNPS) presentó un formulario 8-K para informar que la Oficina de Industria y Seguridad (BIS) del Departamento de Comercio de EE. UU. ha revocado las restricciones de exportación impuestas el 29 de mayo de 2025 sobre ciertos productos de Synopsys vendidos en China. La revocación entra en vigor inmediatamente a partir del 2 de julio de 2025.

La compañía declara que está "trabajando para restaurar el acceso" a los productos previamente restringidos para sus clientes chinos y aún está evaluando cómo estas restricciones temporales podrían afectar su negocio, resultados operativos y situación financiera general. No se proporcionaron impactos cuantitativos ni revisiones de las previsiones en el informe. La dirección recuerda a los inversores que las declaraciones prospectivas están sujetas a riesgos e incertidumbres ya divulgados en informes anteriores de la SEC.

Aunque el 8-K no contiene datos de ganancias, la eliminación de las restricciones elimina un posible obstáculo para las ventas de Synopsys en un mercado estratégicamente importante. El informe no menciona condiciones, sanciones ni limitaciones vigentes relacionadas con la decisión del BIS. La empresa no ha actualizado sus perspectivas y rechaza expresamente cualquier obligación de hacerlo después del 2 de julio de 2025.

Synopsys, Inc. (SNPS)는 2025년 5월 29일 중국에 판매된 일부 Synopsys 제품에 대해 미국 상무부 산업안보국(BIS)이 부과한 수출 제한 조치를 철회했다고 8-K 보고서를 통해 공개했습니다. 이 철회 조치는 2025년 7월 2일부터 즉시 발효됩니다.

회사는 "중국 고객들이 이전에 제한되었던 제품에 다시 접근할 수 있도록 노력하고 있다"며, 이번 임시 제한 조치가 사업, 운영 성과 및 전반적인 재무 상태에 미칠 영향을 아직 평가 중이라고 밝혔습니다. 보고서에는 정량적인 영향이나 가이던스 수정 내용은 포함되어 있지 않습니다. 경영진은 투자자들에게 미래 예측 진술이 이전 SEC 보고서에 공개된 위험과 불확실성에 영향을 받을 수 있음을 상기시켰습니다.

8-K 보고서에는 수익 데이터가 포함되어 있지 않지만, 제한 해제는 전략적으로 중요한 시장에서 Synopsys의 매출에 대한 잠재적 장애물을 제거하는 것입니다. 보고서에는 BIS 결정과 관련된 조건, 벌칙 또는 지속적인 제한 사항이 언급되어 있지 않습니다. 회사는 전망을 업데이트하지 않았으며 2025년 7월 2일 이후에도 업데이트할 의무가 없음을 명확히 밝혔습니다.

Synopsys, Inc. (SNPS) a déposé un formulaire 8-K pour annoncer que le Bureau de l'industrie et de la sécurité (BIS) du Département du commerce des États-Unis a levé les restrictions à l'exportation imposées le 29 mai 2025 sur certains produits Synopsys vendus en Chine. Cette levée prend effet immédiatement à compter du 2 juillet 2025.

L'entreprise indique qu'elle « travaille à rétablir l'accès » pour les clients chinois aux produits précédemment restreints et évalue encore l'impact que ces restrictions temporaires pourraient avoir sur ses activités, ses résultats opérationnels et sa situation financière globale. Aucun impact quantitatif ni révision des prévisions n'ont été fournis dans le dépôt. La direction rappelle aux investisseurs que les déclarations prospectives sont soumises aux risques et incertitudes divulgués dans les rapports antérieurs déposés auprès de la SEC.

Bien que le 8-K ne contienne pas de données sur les résultats, la levée des restrictions supprime un obstacle potentiel aux ventes de Synopsys sur un marché stratégiquement important. Le dépôt ne mentionne aucune condition, pénalité ou limitation en cours liée à la décision du BIS. L'entreprise n'a pas mis à jour ses perspectives et décline expressément toute obligation de le faire après le 2 juillet 2025.

Synopsys, Inc. (SNPS) hat eine 8-K-Meldung eingereicht, um bekanntzugeben, dass das Bureau of Industry and Security (BIS) des US-Handelsministeriums die am 29. Mai 2025 auferlegten Exportbeschränkungen für bestimmte Synopsys-Produkte, die nach China verkauft wurden, aufgehoben hat. Die Aufhebung tritt mit sofortiger Wirkung zum 2. Juli 2025 in Kraft.

Das Unternehmen gibt an, dass es daran arbeitet, den chinesischen Kunden den Zugang zu den zuvor eingeschränkten Produkten wiederherzustellen, und bewertet weiterhin, wie sich die temporären Beschränkungen auf das Geschäft, die Betriebsergebnisse und die finanzielle Gesamtlage auswirken könnten. Im Bericht wurden keine quantitativen Auswirkungen oder Anpassungen der Prognosen angegeben. Das Management erinnert die Investoren daran, dass zukunftsgerichtete Aussagen Risiken und Unsicherheiten unterliegen, die in früheren SEC-Berichten offengelegt wurden.

Obwohl die 8-K-Meldung keine Gewinnzahlen enthält, beseitigt die Aufhebung der Beschränkungen ein potenzielles Hindernis für Synopsys’ Umsatz in einem strategisch wichtigen Markt. Im Bericht werden keine Bedingungen, Strafen oder fortlaufenden Einschränkungen im Zusammenhang mit der BIS-Entscheidung erwähnt. Das Unternehmen hat seinen Ausblick nicht aktualisiert und weist ausdrücklich darauf hin, nach dem 2. Juli 2025 nicht verpflichtet zu sein, dies zu tun.

Positive
  • Immediate lifting of BIS export restrictions removes a significant regulatory barrier to selling Synopsys products in China.
  • Ability to restore product access can help recover any deferred sales and stabilize regional revenue contribution.
Negative
  • Ongoing assessment indicates unresolved uncertainty regarding the financial impact of the prior five-week restriction period.
  • Geopolitical and regulatory risks remain, as BIS retains authority to re-impose controls without advance notice.

Insights

TL;DR: BIS rescission re-opens China sales channel; positive for Synopsys’ EDA revenue trajectory.

The swift reversal of the May 29 restrictions eliminates a key regulatory overhang that could have curtailed growth in China—an important region for electronic design automation (EDA) demand. Although no revenue figures are given, past disclosures identify Asia-Pacific as a double-digit percentage of total sales; regaining full export ability should stabilize that contribution. Investors should monitor how quickly Synopsys reinstates product access and whether any backlog developed during the five-week ban converts to revenue in upcoming quarters. The absence of new conditions suggests low operational friction, but geopolitical risk remains a recurring theme for U.S. semiconductor tool vendors.

TL;DR: Regulatory threat eased but geopolitical risk persists; watch for future export-control volatility.

The rescinded restrictions materially reduce near-term compliance risk and potential revenue loss. However, Synopsys’ acknowledgement that it is "continuing to assess" impact highlights residual uncertainty: (1) sales pipelines may have been disrupted; (2) customers could seek alternatives; and (3) BIS can re-impose controls with little notice. While today’s event is positive, investors should continue to apply a geopolitical risk discount when valuing long-term China exposure.

Synopsys, Inc. (SNPS) ha presentato un modulo 8-K per comunicare che il Bureau of Industry and Security (BIS) del Dipartimento del Commercio degli Stati Uniti ha revocato le restrizioni all'esportazione imposte il 29 maggio 2025 su alcuni prodotti Synopsys venduti in Cina. La revoca è entrata in vigore immediatamente dal 2 luglio 2025.

L'azienda dichiara di essere "al lavoro per ristabilire l'accesso" ai prodotti precedentemente soggetti a restrizioni per i clienti cinesi e sta ancora valutando l'impatto che tali limitazioni temporanee potrebbero avere sul proprio business, sui risultati operativi e sulla situazione finanziaria complessiva. Nel documento non sono stati forniti dati quantitativi né revisioni delle previsioni. La direzione ricorda agli investitori che le dichiarazioni previsionali sono soggette a rischi e incertezze già indicati nei precedenti rapporti SEC.

Pur non contenendo dati sugli utili, la rimozione delle restrizioni elimina un potenziale ostacolo alle vendite di Synopsys in un mercato strategicamente importante. Nel documento non si menzionano condizioni, sanzioni o limitazioni in corso legate alla decisione del BIS. L'azienda non ha aggiornato le proprie previsioni e declina espressamente qualsiasi obbligo di farlo dopo il 2 luglio 2025.

Synopsys, Inc. (SNPS) presentó un formulario 8-K para informar que la Oficina de Industria y Seguridad (BIS) del Departamento de Comercio de EE. UU. ha revocado las restricciones de exportación impuestas el 29 de mayo de 2025 sobre ciertos productos de Synopsys vendidos en China. La revocación entra en vigor inmediatamente a partir del 2 de julio de 2025.

La compañía declara que está "trabajando para restaurar el acceso" a los productos previamente restringidos para sus clientes chinos y aún está evaluando cómo estas restricciones temporales podrían afectar su negocio, resultados operativos y situación financiera general. No se proporcionaron impactos cuantitativos ni revisiones de las previsiones en el informe. La dirección recuerda a los inversores que las declaraciones prospectivas están sujetas a riesgos e incertidumbres ya divulgados en informes anteriores de la SEC.

Aunque el 8-K no contiene datos de ganancias, la eliminación de las restricciones elimina un posible obstáculo para las ventas de Synopsys en un mercado estratégicamente importante. El informe no menciona condiciones, sanciones ni limitaciones vigentes relacionadas con la decisión del BIS. La empresa no ha actualizado sus perspectivas y rechaza expresamente cualquier obligación de hacerlo después del 2 de julio de 2025.

Synopsys, Inc. (SNPS)는 2025년 5월 29일 중국에 판매된 일부 Synopsys 제품에 대해 미국 상무부 산업안보국(BIS)이 부과한 수출 제한 조치를 철회했다고 8-K 보고서를 통해 공개했습니다. 이 철회 조치는 2025년 7월 2일부터 즉시 발효됩니다.

회사는 "중국 고객들이 이전에 제한되었던 제품에 다시 접근할 수 있도록 노력하고 있다"며, 이번 임시 제한 조치가 사업, 운영 성과 및 전반적인 재무 상태에 미칠 영향을 아직 평가 중이라고 밝혔습니다. 보고서에는 정량적인 영향이나 가이던스 수정 내용은 포함되어 있지 않습니다. 경영진은 투자자들에게 미래 예측 진술이 이전 SEC 보고서에 공개된 위험과 불확실성에 영향을 받을 수 있음을 상기시켰습니다.

8-K 보고서에는 수익 데이터가 포함되어 있지 않지만, 제한 해제는 전략적으로 중요한 시장에서 Synopsys의 매출에 대한 잠재적 장애물을 제거하는 것입니다. 보고서에는 BIS 결정과 관련된 조건, 벌칙 또는 지속적인 제한 사항이 언급되어 있지 않습니다. 회사는 전망을 업데이트하지 않았으며 2025년 7월 2일 이후에도 업데이트할 의무가 없음을 명확히 밝혔습니다.

Synopsys, Inc. (SNPS) a déposé un formulaire 8-K pour annoncer que le Bureau de l'industrie et de la sécurité (BIS) du Département du commerce des États-Unis a levé les restrictions à l'exportation imposées le 29 mai 2025 sur certains produits Synopsys vendus en Chine. Cette levée prend effet immédiatement à compter du 2 juillet 2025.

L'entreprise indique qu'elle « travaille à rétablir l'accès » pour les clients chinois aux produits précédemment restreints et évalue encore l'impact que ces restrictions temporaires pourraient avoir sur ses activités, ses résultats opérationnels et sa situation financière globale. Aucun impact quantitatif ni révision des prévisions n'ont été fournis dans le dépôt. La direction rappelle aux investisseurs que les déclarations prospectives sont soumises aux risques et incertitudes divulgués dans les rapports antérieurs déposés auprès de la SEC.

Bien que le 8-K ne contienne pas de données sur les résultats, la levée des restrictions supprime un obstacle potentiel aux ventes de Synopsys sur un marché stratégiquement important. Le dépôt ne mentionne aucune condition, pénalité ou limitation en cours liée à la décision du BIS. L'entreprise n'a pas mis à jour ses perspectives et décline expressément toute obligation de le faire après le 2 juillet 2025.

Synopsys, Inc. (SNPS) hat eine 8-K-Meldung eingereicht, um bekanntzugeben, dass das Bureau of Industry and Security (BIS) des US-Handelsministeriums die am 29. Mai 2025 auferlegten Exportbeschränkungen für bestimmte Synopsys-Produkte, die nach China verkauft wurden, aufgehoben hat. Die Aufhebung tritt mit sofortiger Wirkung zum 2. Juli 2025 in Kraft.

Das Unternehmen gibt an, dass es daran arbeitet, den chinesischen Kunden den Zugang zu den zuvor eingeschränkten Produkten wiederherzustellen, und bewertet weiterhin, wie sich die temporären Beschränkungen auf das Geschäft, die Betriebsergebnisse und die finanzielle Gesamtlage auswirken könnten. Im Bericht wurden keine quantitativen Auswirkungen oder Anpassungen der Prognosen angegeben. Das Management erinnert die Investoren daran, dass zukunftsgerichtete Aussagen Risiken und Unsicherheiten unterliegen, die in früheren SEC-Berichten offengelegt wurden.

Obwohl die 8-K-Meldung keine Gewinnzahlen enthält, beseitigt die Aufhebung der Beschränkungen ein potenzielles Hindernis für Synopsys’ Umsatz in einem strategisch wichtigen Markt. Im Bericht werden keine Bedingungen, Strafen oder fortlaufenden Einschränkungen im Zusammenhang mit der BIS-Entscheidung erwähnt. Das Unternehmen hat seinen Ausblick nicht aktualisiert und weist ausdrücklich darauf hin, nach dem 2. Juli 2025 nicht verpflichtet zu sein, dies zu tun.

SYNOPSYS INC false 0000883241 0000883241 2025-07-02 2025-07-02
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): July 2, 2025

 

 

SYNOPSYS, INC.

(Exact name of registrant as specified in charter)

 

 

 

Delaware   000-19807   56-1546236

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

675 Almanor Ave.

Sunnyvale, California 94085

(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code: (650) 584-5000

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock
(par value of $0.01 per share)
  SNPS   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 8.01 Other Events

On July 2, 2025, Synopsys received a letter from the Bureau of Industry and Security of the U.S. Department of Commerce informing Synopsys that the export restrictions related to China, pursuant to a letter received on May 29, 2025, have now been rescinded, effective immediately. Synopsys is working to restore access to the recently restricted products in China. Synopsys is continuing to assess the impact of export restrictions related to China on its business, operating results and financials.

Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the restoration of access of Synopsys products to our customers in China and the potential impact of the export restrictions. These statements involve risks, uncertainties and other factors, including those factors listed in Synopsys’ most recent reports on Form 10-K and Form 10-Q, that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. The information provided herein is as of July 2, 2025. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

 

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

    SYNOPSYS, INC.
Dated: July 3, 2025     By:  

/s/ John F. Runkel, Jr.

            John F. Runkel, Jr.
            General Counsel and Corporate Secretary

 

3

FAQ

What did Synopsys (SNPS) announce in its July 2, 2025 8-K?

BIS rescinded export restrictions on Synopsys products for China, effective immediately.

When were the original export restrictions imposed?

The restrictions were communicated to Synopsys on May 29, 2025.

Does the filing provide updated financial guidance?

No. Synopsys only states it is assessing the impact and did not revise guidance.

What is Synopsys doing following the rescission?

The company is working to restore access to the previously restricted products for Chinese customers.

Are there any remaining conditions from BIS?

The 8-K mentions no ongoing conditions or penalties; the restrictions are lifted "effective immediately."
Synopsys Inc

NASDAQ:SNPS

SNPS Rankings

SNPS Latest News

SNPS Latest SEC Filings

SNPS Stock Data

76.91B
154.48M
0.42%
91.14%
2.46%
Software - Infrastructure
Services-prepackaged Software
Link
United States
SUNNYVALE